Sentence examples for malignant samples carried from inspiring English sources

In total, 36/70 malignant samples carried the V600E mutation, while all 48 benign samples were wild type for BRAF exon15.

All 118 FNA samples analyzed in this study were molecularly characterized for the presence of the BRAF V600E mutation in exon 15: 36/70 malignant samples carried the V600E mutation, while all 48 benign samples were wild type for BRAF exon 15 (Table  1).

Among the 49 malignant samples, 28 carried the V600E mutation.

The opposite was found for KIT (mean = 0.06 for BRAF V600E; mean = 0.22 for wild-type BRAF, P-value = 0.023) and TC1 (mean = 0.10 for BRAF V600E; mean = 0.47 for wild-type BRAF, P-value = 0.009), which carried the V600E mutation in 28/47 and 34/65 of malignant samples, respectively (Fig.  4).

Unsupervised clustering distinguished unambiguously the benign and malignant samples (data not shown).

Levels of phospho-ELK were significantly lower in normal tissue samples as compared to malignant samples (Figure 2D) (p<0.05).

As noted, the malignant sample 255 is separated from the other two malignant samples, confirming stronger genomic and transcriptomic heterogeneity among malignant samples.

Proteins were divided into less expressed or more expressed in malignant samples compared to benign samples.

To estimate the expression tendency in normal or malignant samples, we calculated the probability of finding a miRNA in malignant samples using hypergeometric test.

Although the malignant and benign group of samples did not show difference in the AI-1/AI-2, the malignant samples showed a statistical significant higher cellular proliferation index.

Malignant cells are carried to the perineurium and endoneurium via the vasa nervorum.